Alimba, Darwin O.
HRN: 22-81-52 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/01/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/01/2023
04/08/2023
IV
600mg
Q8
Non-healing Wound
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes